MLZ Stock Overview
A pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
MediPharm Labs Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.042 |
52 Week High | CA$0.07 |
52 Week Low | CA$0.035 |
Beta | 0.92 |
11 Month Change | -4.93% |
3 Month Change | -2.75% |
1 Year Change | 20.11% |
33 Year Change | -71.18% |
5 Year Change | -98.41% |
Change since IPO | -97.60% |
Recent News & Updates
Recent updates
Shareholder Returns
MLZ | DE Pharmaceuticals | DE Market | |
---|---|---|---|
7D | 1.0% | -1.2% | -0.02% |
1Y | 20.1% | -20.1% | 8.2% |
Return vs Industry: MLZ exceeded the German Pharmaceuticals industry which returned -20.1% over the past year.
Return vs Market: MLZ exceeded the German Market which returned 8.2% over the past year.
Price Volatility
MLZ volatility | |
---|---|
MLZ Average Weekly Movement | 18.1% |
Pharmaceuticals Industry Average Movement | 6.9% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.9% |
10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: MLZ's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: MLZ's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2015 | 166 | David Pidduck | www.medipharmlabs.com |
MediPharm Labs Corp., a pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll cannabis products.
MediPharm Labs Corp. Fundamentals Summary
MLZ fundamental statistics | |
---|---|
Market cap | €18.36m |
Earnings (TTM) | -€8.08m |
Revenue (TTM) | €26.83m |
0.7x
P/S Ratio-2.3x
P/E RatioIs MLZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MLZ income statement (TTM) | |
---|---|
Revenue | CA$39.05m |
Cost of Revenue | CA$25.34m |
Gross Profit | CA$13.71m |
Other Expenses | CA$25.46m |
Earnings | -CA$11.75m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.029 |
Gross Margin | 35.10% |
Net Profit Margin | -30.10% |
Debt/Equity Ratio | 1.3% |
How did MLZ perform over the long term?
See historical performance and comparison